CancerVax Corporation Reports Third Quarter 2003 Financial Results.
Business Wire › December 11, 2003
Linked as:
Extract
CancerVax Corporation Reports Third Quarter 2003 Financial Results.
Business Editors & Health/Medical Writers
BIOWIRE2K CARLSBAD, Calif.--(BUSINESS WIRE)--Dec. 11, 2003 CancerVax Corporation (NASDAQ: CNVX), a biotechnology company focused on the research, development and commercialization of novel biological products for the treatment and control of cancer, announced today financial results for the third quarter of 2003. For the three months ended September 30, 2003, the Company reported a net loss of $10.0 million, as compared to a net loss of $8.1 million for the same period in 2002. For the nine months ended September 30, 2003, CancerVax reported a net loss of $26.4 million, as compared to a net loss of $26.8 million for the same period in 2002. As of September 30, 2003, the Co...See the full content of this document
Sponsored links
